Mark Wencel is a Respiratory physician affiliated with Ascension Via Christi. OpenAlex indexes 7 publications with 221 citations (h-index 4); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3311 E Murdock St
Wichita, KS 672083054
Telephone
316-689-9325Registry record last updated 16 Jul 2007.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
44.9%Macrolide Antimicrobial44.9%Azithromycin100%Part D≥20 patientsRespiratory
31.6%beta2-Adrenergic Agonist16%Albuterol Sulfate Hfa39%Proair Hfa31%Ventolin Hfa31%Part D<11 patientsCorticosteroid15.6%Symbicort54%Breo Ellipta46%Part D<11 patientsMetabolism & gastrointestinal
23.6%Corticosteroid18.2%Prednisone100%Part D≥13 patientsProton pump inhibitor5.3%Omeprazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Using forced vital capacity (FVC) in the clinic to monitor patients with idiopathic pulmonary fibrosis (IPF): pros and cons
Expert Review of Respiratory Medicine
2020 - Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis
Chronic Respiratory Disease
2019
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”